I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 24% ± 7% | |
| natural killer cell | 5 studies | 19% ± 4% | |
| retinal rod cell | 4 studies | 29% ± 11% | |
| endothelial cell | 4 studies | 19% ± 4% | |
| B cell | 3 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| non-classical monocyte | 3 studies | 26% ± 10% | |
| retinal bipolar neuron | 3 studies | 22% ± 7% | |
| retinal cone cell | 3 studies | 32% ± 11% | |
| fibroblast | 3 studies | 18% ± 1% | |
| GABAergic neuron | 3 studies | 32% ± 3% | |
| glutamatergic neuron | 3 studies | 40% ± 8% |
